The Use of Mucograft® to Treat Gingival Recession

Damascus University

Status

Completed

Conditions

Gingival Recession

Treatments

Procedure: Mucograft

Procedure: Connective Tissue Graft

Study type

Interventional

Funder types

Other

Identifiers

NCT02986191

UDDS-Perio-01-2016

Details and patient eligibility

About

Twenty patients with gingival recession will be enrolled in this trial. Gingival recession will be treated in one side by applying Mucograft® with coronally advanced flap (CAF) while on the opposite side a connective tissue graft (from the palate) will be applied with a CAF.

Patients will be followed for 3 and 6 months by measuring the clinical indexes and statistical analyses will be performed to compare the results and to assess the success of Mucograft®.

Full description

Many surgical techniques have used to treat gingival recession such aas repositioned flaps, autologous soft tissue grafts (connective tissue graft or free gingival grafts) or allografts like acellular dermal which can be used as substitutes for palatal donor tissue. Mucograft® (3D collagen matrix) is also an allograft from porcine origin and is designed for soft tissue regeneration and considered the ideal solution to autogenous soft tissue grafts and it provides an ideal matrix for blood vessel and soft tissue ingrowth.

Enrollment

20 patients

Sex

All

Ages

20 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Presence of Type I or II (Miller Classification) of gingival recession

Exclusion criteria

Smoking
Pregnancy or lactating
Presence of any systematic diseases can affect the periodontal surgery.
Subjects with significant moderate to severe periodontal disease.
Patients under orthodontic treatment
Presence of restorative materials (e.g. crown)
Effectiveness of frenum
Subjects have failed to maintain good plaque control.
Subjects having previous surgical treatment for covering the recession in the chosen area.